According to VBI Vaccines 's latest financial reports the company's current EPS (TTM) is -โน1,187. In 2022 the company made an earnings per share (EPS) of -โน1,134 a decrease over its 2021 EPS that were of -โน697.01.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -โน1,132 | -0.14% |
2022 | -โน1,134 | 62.69% |
2021 | -โน697.01 | 28.57% |
2020 | -โน542.12 | -53.33% |
2019 | -โน1,162 | -53.61% |
2018 | -โน2,504 | 10.23% |
2017 | -โน2,272 | 22.22% |
2016 | -โน1,859 | -94.55% |
2015 | -โน34,077 | 728.93% |
2014 | -โน4,111 | 92.1% |
2013 | -โน2,140 | -66.24% |
2012 | -โน6,339 | -77.97% |
2011 | -โน28,778 | 217.82% |
2010 | -โน9,055 | 954.43% |
2009 | -โน858.74 | -2273.56% |
2008 | โน39.51 | -209.82% |
2007 | -โน35.98 | -42.44% |
2006 | -โน62.51 | -82.2% |
2005 | -โน351.18 | 2797.22% |
2004 | -โน12.12 | -41.9% |
2003 | -โน20.86 | -99.17% |
2002 | -โน2,525 | 8.12% |
2001 | -โน2,336 |